Commentaire :

ISBN 13 : 978-3-527-32435-4

Sommaire : Contents

Limit of Liability / Disclaimer of Warranty.

1. Introduction.
1.1 Development of the Private Equity and Venture Capital Market.
1.2 Development of the Biotech Industry.

2. Methodology.
2.1 Formulating the Research Goal.
2.2 Conducting the Study.
2.3 Evaluating the Results.

3. Data Analysis and Interpretation of Results.
3.1 Description of Interview Partners.
3.2 Major Characteristics of an Entrepreneur.
3.3 Major Characteristics of a Venture Capitalist.
3.4 The Most Important Partnering Criteria.
3.5 Financing Models.
3.6 Biotech Research Areas.
3.7 Alliances and Funding in the Early Stage.
3.8 Alliances and Funding in the Late Stage.
3.9 Exit Routes.
3.10 Primary Causes of Failure.
3.11 Best-practice Countries for Funding Biotech Start-ups.
3.12 Most Striking Differences between the US and European Venture Capital Markets.

4. Biotech Case Studies.
4.1 AUSTRIANOVA Biomanufacturing AG.

4.2 AVIR Green Hills Biotechnology AG.
4.3 EUCODIS GmbH
4.4 Intercell AG.
4.5 onepharm Research & Development GmbH.

5. Summary and Conclusions.
5.1 The Challenge: When Science Meets Business.
5.2 Checklists.
5.3 Final Observations.

6. Outlook and Recommendations.

Epilogue.
References.

Appendix A: List of Abbreviations.
Appendix B: Glossary.
Appendix C.
Appendix D: Questionnaires.

Langue : Anglais

Lieu d'édition : TORONTO

Illustration(s) : Schémas

Localisation : Bibliothèque Campus de Nice

Support : Papier

Etat : Présent

Propriétaire : Bibliothèque